autologous umbilical cord blood-derived mononuclear cells (Mayo Clinic)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous umbilical cord blood-derived mononuclear cells (Mayo Clinic)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Myogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart Defects, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsHeart Defects, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A